Iradimed (IRMD) Return on Capital Employed (2014 - 2026)
Iradimed (IRMD) posted quarterly Return on Capital Employed of 26.11% for Q2 2026, up 112.0% year-over-year from 12.32% in Q2 2025, and down 7.08% on a QoQ basis from 28.1% in Q1 2026.
Iradimed (IRMD) Return on Capital Employed (2014 - 2026) Analysis & Trends
Iradimed has reported Return on Capital Employed for 13 years, with the latest figure at 26.11% in Q2 2026.
- Return on Capital Employed for Q2 2026 came in at 26.11%, up 112.0% year-over-year; the trailing twelve-month figure through Jun 2026 was 26.11% (up 112.0% YoY), and the FY2025 annual result was 28.0%, up 268.0% from the prior year.
- Return on Capital Employed fell to 26.11% in Q2 2026, from 28.1% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 28.1% in Q1 2026 and troughed at 15.57% in Q1 2022.
- A 5-year average of 24.04% and a median of 25.01% in 2023 frame the typical range for Return on Capital Employed.
- The widest annual swing landed in 2022, when Return on Capital Employed surged 1515 bps; it then tumbled 225 bps in 2024.
- A 5-year view of Return on Capital Employed shows it stood at 21.13% in 2022, then rose by 29 bps to 27.28% in 2023, then dropped by 8 bps to 25.02% in 2024, then advanced by 3 bps to 25.74% in 2025, then grew by 1 bps to 26.11% in 2026.
- Per Business Quant data, the three most recent Return on Capital Employed figures were 26.11% in Q2 2026, 28.1% in Q1 2026, and 25.74% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 12.08% |
| 10 | Iradimed | 1.12 Bn | 1.06 Bn | 15.16 Mn | 26.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26.11% |
| Mar 31, 2026 | 28.10% |
| Dec 31, 2025 | 25.74% |
| Sep 30, 2025 | 25.42% |
| Jun 30, 2025 | 24.99% |
| Mar 31, 2025 | 24.74% |
| Dec 31, 2024 | 25.02% |
| Sep 30, 2024 | 25.38% |
| Jun 30, 2024 | 26.30% |
| Mar 31, 2024 | 25.19% |
| Dec 31, 2023 | 27.28% |
| Sep 30, 2023 | 24.99% |
| Jun 30, 2023 | 24.47% |
| Mar 31, 2023 | 22.44% |
| Dec 31, 2022 | 21.13% |
| Sep 30, 2022 | 20.11% |
| Jun 30, 2022 | 19.78% |
| Mar 31, 2022 | 15.57% |
| Dec 31, 2021 | 13.30% |
| Sep 30, 2021 | 10.41% |